Default company panoramic image

Meda Biotech llc

The technology platform called HYBRID-NANOENGINEERING™.A new treatment for cancer. Discovery for synergistic effects of nanomedicine.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Zachary, LA, USA
  • Currency USD
  • Founded March 2002
  • Website

Company Summary

After 2012 things become really interesting, the value of these nano-enabled compounds will sky rocket, reaching $220 billion by 2015. More than 45% molecules, either in the market, or in research or in clinical trials or in pieline are in need of this kind of technology. We have it all. The most advanced nanotechnology platform for drug delivery. A strong patent to beat generic clift. A new cancer treatment from Meda biotech.


  • Default avatar
    mewa singh

    Five Patents
    Over 25 products from Proof of concept to final stage
    Founder three Biopharmaceutical companies with own investment
    145 Nanomedicines for Pharmaceuticals, Nutraceuticals and Agrochemicals


    PhD 1991 Microbiology and Immunology, Master in biochemistry.

  • Default avatar
    na na

    Goals are to make a difference in Life using Nanotechnology to develop nanomedicines for various diseases. For the benefits of individuals of developed and under developed countries.

    Attached is information (YouTube)

  • Over 24 years’ experience in the field of biopharmaceuticals with a strong knowledge in Biotechnology, pharmaceuticals business market and product development.

    Performed at administrative and senior management positions which included (Director of R&D, Chief Scientific Officer, COO and CEO), Chembio diagnostics,
    Founded or co-founded over 7 companies in United State, India and China.

Previous Investors

  • Default avatar
    Mewa singh
    Default avatar
    Nano Biotech India